Unknown

Dataset Information

0

Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells.


ABSTRACT: p53 transduction is a potentially effective cancer therapy but does not result in a good therapeutic response in all human cancers due to resistance to apoptosis. To discover factors that overcome resistance to p53-induced apoptosis, we attempted to identify RNAi sequences that enhance p53-induced apoptosis. We screened a genome-wide lentiviral shRNA library in liver cancer Huh-7 and pancreatic cancer Panc-1 cells, both of which resist p53-induced apoptosis. After the infection of adenovirus expressing p53 or LacZ as a control, shRNA-treated populations were analyzed by microarray. We identified shRNAs that were significantly decreased in p53-infected cells compared with control cells. Among these shRNAs, shRNA-58335 was markedly decreased in both cancer cell lines tested. shRNA-58335 enhanced p53-related apoptosis in vitro and augmented the inhibitory effect of adenoviral p53 transduction on tumor growth in vivo. Furthermore, the enhanced apoptotic response by shRNA-58335 was also confirmed by treatment with PRIMA-1, which reactivates mutant p53, instead of adenoviral p53 transduction. We found that shRNA-58335 evokes the apoptotic response following p53 transduction or functional restoration of p53 with a small molecule drug in cancer cells resistant to p53-induced apoptosis. The combination of p53 restoration and RNAi-based drugs is expected to be a promising novel cancer therapy.

SUBMITTER: Idogawa M 

PROVIDER: S-EPMC4202142 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4304782 | BioStudies
1000-01-01 | S-EPMC2839214 | BioStudies
1000-01-01 | S-EPMC2867740 | BioStudies
2009-01-01 | S-EPMC2745301 | BioStudies
2007-01-01 | S-EPMC1832123 | BioStudies
1000-01-01 | S-EPMC2824726 | BioStudies
2012-01-01 | S-EPMC3411659 | BioStudies
2018-01-01 | S-EPMC5978436 | BioStudies
2018-01-01 | S-EPMC6146707 | BioStudies
2014-01-01 | S-EPMC4074332 | BioStudies